葡萄牙在2040年之前对外部光束放射治疗的未来需求
E D Rodrigues1, P Almeida2, E López Ramírez3
1Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal; CINTESIS - Center for Health Technology and Services Research/ RISE - Health Research Network, Porto, Portugal.
概括
葡萄牙到2040年需要18-30台新的外部光束放射治疗 (EBRT) 机器,以满足不断增长的癌症治疗需求. 这项投资对于可访问,高质量的癌症护理至关重要,需要重大政策变化和资金.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 卫生经济学 卫生经济学
背景情况:
- 外部光束放射治疗 (EBRT) 对于癌症治疗至关重要,但面临着全球基础设施和投资短缺的问题.
- 这些缺陷损害了癌症患者的治疗结果,强调了战略规划的必要性.
研究的目的:
- 量化葡萄牙在2040年之前对EBRT的未来需求.
- 估计所需的基础设施和人员,以满足预计的需求.
主要方法:
- 利用全球癌症观测中心的数据来估计葡萄牙2040年的癌症病例.
- 根据已确定的指南 (IAEA,ESTRO) 计算出最佳EBRT课程.
- 确定必要的EBRT机器 (MV单元) 和人员水平 (辐射瘤学家,医学物理学家,治疗师).
主要成果:
- 预计到2040年,最佳EBRT课程将增加18%,总计约为34,000.
- 估计需要18-30个新的EBRT机器/MV单元.
- 需要的人员包括28-46名放射瘤学家,22-36名医学物理学家和61-102名放射治疗师.
结论:
- 葡萄牙面临着EBRT基础设施的重大赤字.
- 解决这一问题需要政策改革和投资,以确保公平获得放射治疗.
相关概念视频
Biological Effects of Radiation
15.4K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.4K
Absorption of Radiation
712
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
712
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


